Compare the costs and market impact of authorized generics versus first-to-file generics. Learn how FTC data shows price drops, revenue impacts, and the role of the Hatch-Waxman Act in drug pricing.
Explore how pharmaceutical companies use market exclusivity extensions beyond patents to delay generics. Learn about Hatch-Waxman, PTE, SPCs, and regulatory stacking strategies.
Discover why generic medications cost significantly less than brand-name drugs. Learn about the Hatch-Waxman Act, FDA regulations, and how competition drives down prices, saving patients billions annually.